PCRX
Pacira BioSciences Inc

1,567
Mkt Cap
$941.79M
Volume
798,804.00
52W High
$27.64
52W Low
$18.80
PE Ratio
148.06
PCRX Fundamentals
Price
$23.26
Prev Close
$23.53
Open
$23.30
50D MA
$22.18
Beta
0.39
Avg. Volume
836,694.97
EPS (Annual)
$0.1562
P/B
1.38
Rev/Employee
$876,249.70
$1,345.47
Loading...
Loading...
News
all
press releases
Radcliffe Capital Management L.P. Takes $1.23 Million Position in Pacira BioSciences, Inc. $PCRX
Radcliffe Capital Management L.P. bought a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc. DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences...
PR Newswire·4d ago
News Placeholder
Pacira BioSciences (NASDAQ:PCRX) Downgraded to "Strong Sell" Rating by Zacks Research
Zacks Research cut Pacira BioSciences from a "hold" rating to a "strong sell" rating in a research report on Monday...
MarketBeat·4d ago
News Placeholder
Pacira BioSciences (NASDAQ:PCRX) Stock Price Up 4.6% - What's Next?
Pacira BioSciences (NASDAQ:PCRX) Shares Up 4.6% - What's Next...
MarketBeat·12d ago
News Placeholder
Wall Street Zen Downgrades Pacira BioSciences (NASDAQ:PCRX) to Buy
Wall Street Zen cut Pacira BioSciences from a "strong-buy" rating to a "buy" rating in a report on Saturday...
MarketBeat·15d ago
News Placeholder
Pacira BioSciences (NASDAQ:PCRX) Shares Gap Down - What's Next?
Pacira BioSciences (NASDAQ:PCRX) Shares Gap Down - Here's What Happened...
MarketBeat·16d ago
News Placeholder
Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down
PCRX misses Q4 earnings and revenue estimates as expenses surge and shares slide, despite Exparel growth and a new 2026 outlook.
Zacks·16d ago
News Placeholder
Pacira BioSciences Q4 Earnings Call Highlights
Pacira BioSciences (NASDAQ:PCRX) executives used the company's fourth-quarter and full-year 2025 earnings call to highlight what CEO Frank Lee described as a transformative year, pointing to renewed...
MarketBeat·16d ago
News Placeholder
Pacira BioSciences (NASDAQ:PCRX) Releases Earnings Results, Misses Expectations By $0.28 EPS
Pacira BioSciences (NASDAQ:PCRX - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.57 earnings per share (EPS) for the quarter, missing the consensus...
MarketBeat·16d ago
News Placeholder
Compared to Estimates, Pacira (PCRX) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Pacira (PCRX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·16d ago
<
1
2
...
>

Latest PCRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.